• Exchange: London
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

Ark Therapeutics Group PLC

+ Add to Watchlist

AKT:LN

Trading has been suspended for AKT:LN

Snapshot for Ark Therapeutics Group PLC (AKT)

Open: - Day's Range: - Volume: 0
Previous Close: 0.535 52wk Range: 0.280 - 0.800 1-Yr Rtn: -

Stock Chart for AKT

No chart data available.
  • AKT:LN 0.535
  • 1M
  • 1Y
0.535
Interactive AKT Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for AKT

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. UKX -
Earnings Per Share (GBP) (ttm) 0.0050
Est. EPS (GBP) (12/2014) -
Est. PEG Ratio -
Market Cap (M GBP) 0.00
Shares Outstanding (M) 209.28
30 Day Average Volume 0
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 08/29/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for AKT

  • Revenue
  • Net Income (M/GBP)
  • Profit Margin (%)

Company Profile & Key Executives for AKT

Ark Therapeutics Group PLC develops medicinal gene-based and biological therapies and diagnostic products. The Company develops products to treat vascular disease and cancer.

Sue StevenSecretary
More Company Profile & Key Executives for AKT

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil